Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008840 |
ID: | TCMBANKHE008840 |
植物拉丁名: |
|
药用植物名: | 龙舌兰 |
TCM_ID_id: | 1922 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN006937 | lotaustralin | lotaustralin | C11H19NO6 | 261.27 g/mol | CCC(C)(C#N)OC1C(C(C(C(O1)CO)O)O)O |
| TCMBANKIN015691 | n-methylmescaline | AKOS000277427; Benzeneethanamine,3,4,5-trimethoxy-N-methyl-; CHEBI:7319; KB-295584; Benzenethanamine,3,4,5-trimethoxy-N-methyl-; Benzeneethanamine, 3,4,5-trimethoxy-N-methyl-; CTK1D6604; OTXANOLOOUNVSR-UHFFFAOYSA-N; N-methyl-3,4,5-trimethoxyphenethylamine; C08310; SCHEMBL4320087; N-Methyl-2-(3,4,5-trimethoxyphenyl)ethanamine; N-methyl-N-[2-(3,4,5-trimethoxy-phenyl)-ethyl]-amine; AC1L3CNA; N-Methyl-2-(3,4,5-trimethoxyphenyl)ethanamine #; Benzenethanamine, 3,4,5-trimethoxy-N-methyl-; N-Methylmescaline; 4838-96-4; N-Methyl-3,4,5-trimethoxybenzeneethanamine; ZINC1531060; DTXSID00197505; Mescaline, N-methyl-; CHEMBL100531; BG01527645 | C12H19NO3 | 225.28 g/mol | CNCCC1=CC(=C(C(=C1)OC)OC)OC |
| TCMBANKIN023408 | 3-methyl-6-methoxy-8-hydroxy-3,4-dihydroisocoumarin | 3-methyl-6-methoxy-8-hydroxy-3,4-dihydro-isocoumarin | C11H12O4 | 208.21 g/mol | CC1CC2=C(C(=CC(=C2)OC)O)C(=O)O1 |
| TCMBANKIN029304 | lophophorine | C13H17NO3 | 235.28 g/mol | CC1C2=C3C(=C(C=C2CCN1C)OC)OCO3 | |
| TCMBANKIN034182 | mesembrenone | C17H21NO3 | 287.35 g/mol | CN1CCC2(C1CC(=O)C=C2)C3=CC(=C(C=C3)OC)OC | |
| TCMBANKIN058162 | LDP | nchembio801-comp8; SPBio_001205; Spectrum3_000406; 51-61-6; cMAP_000036; KBio2_006628; Spectrum5_000945; DOPAMINE; KBio3_002867; 3-Hydroxtyramine; KBio3_002962; nchembio705-8; 4-(2-Aminoethyl)benzene-1,2-diol; 3, 4-Dihydroxyphenethylamine hydrochloride; 4-(2-aminoethyl)-pyrocatechol; 62-31-7 (HYDROCHLORIDE); Pyrocatechol, 4-(2-aminoethyl)-; Intropin {[as} hydrochloride]; NSC 173182; 4-(2-Aminoethyl)-1,2-bezenediol; KBioSS_001492; EINECS 200-110-0; cMAP_000065; Lopac-H-8502; KBio2_005052; KBioSS_002393; Dophamine; KBio2_004060; HSDB 3068; L-DOPAMINE; 4-(2-Aminoethyl)pyrocatechol; KW-3-060; BSPBio_001932; AIDS156129; KBioGR_002484; NCGC00096050-02; 3,4-Dihydroxyphenylethylamine; KBio2_004956; Spectrum2_001023; NSC169105 (HYDROCHLORIDE); Spectrum4_000525; (3H)-Dopamine; KBioGR_001129; 3-Hydroxytyramine; C03758; Dopamin; KBio2_007620; Dopaminum [INN-Latin]; m-Hydroxytyramine-; BPBio1_001123; Pyrocatechol, 4-(2-aminoethyl)- (8CI); alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; KBioGR_002388; Biomol-NT_000001; 2-(3,4-dihydroxyphenyl)ethylamine; Lopac0_000586; Hydroxytyramin; DivK1c_000780; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)-1,2-benzenediol; CHEBI:18243; 3,4-dihydroxyphenethylamine; 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI); IDI1_000780; NCGC00015519-01; NSC173182; 1,2-Benzenediol, 4-(2-aminoethyl)-; 50444-17-2; Oprea1_088821; hydroxytyramine; SBB004044; NCGC00096050-01; .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane; Spectrum_001012; Dopamine (USAN)(*hydrochloride*); KBio2_002388; KBio3_001152; nchembio.78-comp16; Oxytyramine; KBio2_001492; KBioSS_002491; KBio1_000780; AIDS-156129; KBio2_002484; NINDS_000780; NCGC00096050-04; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; Dopamina [INN-Spanish]; KBio2_007524; SPECTRUM1505155; a-(3,4-Dihydroxyphenyl)-b-aminoethane; dopamine | C8H11NO2 | 153.18 g/mol | C1=CC(=C(C=C1CCN)O)O |
| TCMBANKIN058252 | tyramine | AIDS018687; 4-(2-aminoethyl)phenol; p-.beta.-Aminoethylphenol; NINDS_000918; Spectrum2_000738; Spectrum3_000693; Phenol, p-(2-aminoethyl)-; HSDB 2132; tyraminium cation; to_000085; 2-(4-hydroxyphenyl)ethylammonium; Tenosin-Wirkstoff; tyraminium(1+); Spectrum5_000501; Lopac-T-2879; 4-Hydroxyphenethylamine; NSC249188; InChI=1/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H; BSPBio_002445; SMR000059295; Oprea1_294339; SGCUT00017; AC1NRWHX; KBio2_004261; Uteramine; BB_NC-1362; 2-(4-hydroxyphenyl)ethylazanium; 2-(4-Hydroxyphenyl)ethylamine; SPBio_000696; 3bra; Phenethylamine, p-hydroxy-; Spectrum4_001801; NCGC00063825-05; BRN 1099914; 4-Hydroxy-.beta.-phenylethylamine; 4-Hydroxyphenethylamine ((tyramine); 2-(p-Hydroxyphenyl)ethylamine; 93810_FLUKA; KBio1_000918; 51-67-2 (FREE BASE); NSC 249188; NCGC00063825-04; p-Hydroxy-.beta.-phenethylamine; NCGC00016011-01; 59880-97-6 (HCL); BPBio1_001394; ZB000512; 4-(2-Aminoethyl)phenol; KBioSS_001693; p-Hydroxyphenylethylamine; DivK1c_000918; p-Hydroxyphenethylamine; p-beta-Aminoethylphenol; NCGC00063825-07; .alpha.-(4-Hydroxyphenyl)-.beta.-aminoethane; IDI1_000918; Benzeneethanamine, 4-hydroxy-; tyraminium; WLN: Z2R DQ; beta-Hydroxyphenylethylamine; A828724; alpha-(4-Hydroxyphenyl)-beta-aminoethane; KBio2_001693; KBio3_001665; p-Tyramine; 4-Hydroxyphenylethylamine; T90344_ALDRICH; Tocosine; KBio2_006829; MLS000079096; Phenol, 4-(2-aminoethyl)-; EINECS 200-115-8; BDBM50067723; 2-(4-hydroxyphenyl)ethanaminium; Tyrosamine; .beta.-(4-Hydroxyphenyl)ethylamine; C00483; Biomol-NT_000075; Tyramine; Systogene; 4-13-00-01788 (Beilstein Handbook Reference); p-(2-Aminoethyl)phenol; 51-67-2; 2-(4-Hydroxy-phenyl)-ethyl-ammonium; Spectrum_001213; Lopac0_001136; NCGC00063825-08; CJ-00085; CHEBI:15760; CHEBI:327995; KBioGR_002405; SPECTRUM210400; LS-189905; (4-hydroxyphenethyl)ammonium; AIDS-018687; Tyramin; 4-Hydroxyphenethylaminium | C8H11NO | 137.18 | C1=CC(=CC=C1CCN)O |
| TCMBANKIN058255 | Tyrosol | NSC 59876; 4-Hydroxybenzeneethanol; P-HYDROXYPHENETHYL ALCOHOL; NSC59876; tyrosol; 56105_FLUKA; Benzeneethanol, 4-hydroxy-; 2-(4-Hydroxyphenyl)ethanol; 4-Hydroxyphenethyl alcohol; 2-(P-HYDROXYPHENYL)ETHANOL; ZINC00164581; SB 01196; 4-(2-hydroxyethyl)phenol; InChI=1/C8H10O2/c9-6-5-7-1-3-8(10)4-2-7/h1-4,9-10H,5-6H; EINECS 207-930-8; 4-Hydroxyphenylethanol; CHEBI:1879; 501-94-0; 188255_ALDRICH; 79058_FLUKA; C06044; 2-(4-hydroxyphenyl)-ethanol; 4-hydroxyphenethyl alcohol; p-hydroxyphenylethanol; p-hydroxyphenethyl alcohol; 2-(4-hydroxyphenyl)ethanol; p-hydroxyphenylethyl alcohol | C8H10O2 | 138.16 g/mol | C1=CC(=CC=C1CCO)O |
| TCMBANKIN059702 | adonixanthin | C40H54O3 | 582.9 g/mol | CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C(=O)C(CC2(C)C)O)C)C)C | |
| TCMBANKIN061789 | TMPEA | EINECS 200-190-7; NSC30419; 2-(3,4,5-Trimethoxyphenyl)ethylamine; DEA No. 7381; Benzeneethanamine, 3,4,5-trimethoxy-; Mescalin; 2-(3,4,5-trimethoxyphenyl)ethanamine; NINDS_000984; Mezcline; 3,4,5-Trimethoxy-b-phenethylamine; IDI1_000984; DivK1c_000984; Mezcalin; Benzeneethanamine, 3,4,5-trimethoxy- (9CI); Mescaline; Phenethylamine, 3,4,5-trimethoxy-; Phenethylamine, 3,4,5-trimethoxy- (8CI); 54-04-6; Mezcaline; KBio1_000984; Constituent of "Peyote" cacti; 3,4,5-Trimethoxybenzeneethanamine; NSC 30419; 3,4,5-Trimethoxyphenylethylamine; Ethane, 1-amino-2-(3,4,5-trimethoxyphenyl)-; Oprea1_166025; 4-13-00-02919 (Beilstein Handbook Reference); 3,4,5-Trimethoxyphenethylamine; Mescalin [German]; WLN: Z2R CO1 DO1 EO1; Mescline; BRN 1374088; C06546;mescaline;Meskalin; Mescalin; DEA No. 7381; Mezcline; NSC-30419; 1-amino-2-(3,4,5-trimethoxyphenyl)ethane; Constituent of Peyote cacti; Tmpea; SCHEMBL34190; Phenethylamine, 3,4,5-trimethoxy-; 3,4,5-trimethoxy-phenethylamine; Benzeneethanamine,4,5-trimethoxy-; 3,4,5-Trimethoxybenzeneethanamine; A-7488; Ethane, 1-amino-2-(3,4,5-trimethoxyphenyl)-; 3,4,5-trimethoxy-phenylethylamine; 2-(3,4,5-Trimethoxyphenyl)ethanamine; C06546; Benzeneethanamine,3,4,5-trimethoxy-; RHO99102VC; EINECS 200-190-7; mezcalina; 2-(3,4,5-trimethoxyphenyl)-ethylamine; NSC30419; mescalina; 2-(3,4,5-Trimethoxyphenyl)ethylamine; UNII-RHO99102VC; LS-103730; 2-(3,4,5-Trimethoxyphenyl)ethanamine #; Peyote; Ethane,4,5-trimethoxyphenyl)-; 2-(3,4,5-trimethoxy-phenyl)-ethylamine; NSC 30419; D0L8MR; 3,4,5-trimethoxyphenethyl-amine; Mescline; Y9395; HSDB 7503; AJ-08069; Benzeneethanamine, 3,4,5-trimethoxy-; CHEBI:28346; 3,4,5-Trimethoxy-b-phenethylamine; 1954/4/6; DivK1c_000984; IDI1_000984; Mezcalin; AC1L1HCV; Benzeneethanamine, 3,4,5-trimethoxy- (9CI); Phenethylamine, 3,4,5-trimethoxy- (8CI); Mezcaline; KBio1_000984; ZINC1689; DTXSID80202303; CHEMBL26687; 2-(3,4,5-trimethoxy-phenyl)ethylamine; WLN: Z2R CO1 DO1 EO1; NINDS_000984; Constituent of ""Peyote"" cacti; BDBM50059891; RP04786; AKOS000277426; AK153291; J-505719; RHCSKNNOAZULRK-UHFFFAOYSA-N; 3,4,5-Trimethoxyphenylethylamine; 3,5-Trimethoxyphenethylamine; CTK4J9394; 2-(3,4,5-trimethoxyphenyl)-ethyl-amine; Oprea1_166025; 3,5-Trimethoxyphenylethylamine; MFCD00128240; (3,4,5-trimethoxy)-benzylmethylamine; 3,4,5-Trimethoxyphenethylamine; Mescalin [German]; NCGC00247674-01; BRN 1374088 | C11H17NO3 | 211.26 g/mol | COC1=CC(=CC(=C1OC)OC)CCN |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab